株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

MRI (核磁気共鳴画像法) システム:医療機器のパイプライン評価

MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 633277
出版日 ページ情報 英文 359 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.53円で換算しております。
Back to Top
MRI (核磁気共鳴画像法) システム:医療機器のパイプライン評価 MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline Assessment, 2019
出版日: 2019年05月01日 ページ情報: 英文 359 Pages
概要

当レポートでは、世界のMRI (核磁気共鳴画像法) 装置市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • MRI (核磁気共鳴画像) システムの概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:部門別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 MRIシステム:各企業で現在治験中のパイプライン製品

  • MRIシステム企業:治験段階別のパイプライン製品
  • MRIシステム:治験段階別のパイプライン製品

第5章 MRIシステムの企業・製品の概要

  • Advanced MRI Technologies
  • ALA Scientific Instruments Inc
  • Aspect Imaging Inc
  • Boston Children's Hospital
  • Brigham and Women's Hospital
  • C4 Imaging, LLC
  • キヤノンメディカルシステムズ
  • Cincinnati Children's Hospital Medical Center
  • Clear Cut Medical Ltd.
  • Diagnosoft Inc
  • Duke University
  • GE Global Research
  • GE Healthcare LLC
  • Georgetown University
  • Harvard University
  • Hugo W. Moser Research Institute at Kennedy Krieger Inc
  • Icahn School of Medicine at Mount Sinai
  • Johns Hopkins University
  • KinetiCor Inc
  • Koninklijke Philips N.V.
  • Leiden University
  • Leiden University Medical Center
  • Marvel Medtech LLC
  • Massachusetts General Hospital
  • Max Delbruck Center for Molecular Medicine
  • Medical College of Wisconsin
  • 三菱電機
  • MRI Robotics LLC
  • Neurospin
  • New York University School of Medicine
  • Northwestern University
  • Oregon Health & Science University
  • Philips Healthcare
  • Picofemto LLC
  • Prism Clinical Imaging, Inc.
  • Promaxo Inc
  • Resonance Health Ltd
  • Robin Medical, Inc.
  • Siemens Healthcare GmbH
  • Stanford University
  • Superconducting Systems Inc
  • Tel Aviv University
  • Time Medical, Inc.
  • Tornado Spectral Systems
  • University of California Davis
  • University of California Los Angeles
  • University of Colorado
  • University of Illinois
  • University of Louisville
  • University of Manchester
  • University of Michigan
  • University of Nottingham
  • University of Queensland
  • University of Saskatchewan
  • University of Strasbourg
  • University of Texas Southwestern Medical Center
  • University of Virginia
  • University of Washington
  • Vanderbilt University
  • VisionQuest Biomedical LLC
  • Weinberg Medical Physics, LLC
  • Weizmann Institute of Science
  • Wright State University

第6章 MRIコイル市場:昨今の動向

第7章 付録

図表

1.1 List of Tables

  • Table 1: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Stage of Development
  • Table 2: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Segment
  • Table 3: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Territory
  • Table 4: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Regulatory Path
  • Table 5: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Estimated Approval Date
  • Table 6: MRI (Magnetic Resonance Imaging) Systems - Ongoing Clinical Trials
  • Table 7: MRI (Magnetic Resonance Imaging) Systems Companies - Pipeline Products by Stage of Development
  • Table 8: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Stage of Development
  • Table 9: Advanced MRI Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: MRI Cerebral Perfusion Imaging Tool - Product Status
  • Table 11: MRI Cerebral Perfusion Imaging Tool - Product Description
  • Table 12: Multiplexed EPI Imaging Sequence - Product Status
  • Table 13: Multiplexed EPI Imaging Sequence - Product Description
  • Table 14: ALA Scientific Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: fMRI Device - Brain Injury - Product Status
  • Table 16: fMRI Device - Brain Injury - Product Description
  • Table 17: Aspect Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Stroke-dedicated MRI System - Product Status
  • Table 19: Stroke-dedicated MRI System - Product Description
  • Table 20: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Fetal Neuroimaging - Product Status
  • Table 22: Fetal Neuroimaging - Product Description
  • Table 23: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Diffusion Magnetic Resonance Imaging Tool - Chronic Traumatic Encephalopathy - Product Status
  • Table 25: Diffusion Magnetic Resonance Imaging Tool - Chronic Traumatic Encephalopathy - Product Description
  • Table 26: Magnetic Resonance Elastography - Product Status
  • Table 27: Magnetic Resonance Elastography - Product Description
  • Table 28: MRI - Head And Knee Imaging - Product Status
  • Table 29: MRI - Head And Knee Imaging - Product Description
  • Table 30: C4 Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Sirius MRI Marker - Product Status
  • Table 32: Sirius MRI Marker - Product Description
  • Table 33: Sirius MRI Marker - Multi-Modality Imaging - Product Status
  • Table 34: Sirius MRI Marker - Multi-Modality Imaging - Product Description
  • Table 35: Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Vantage Titan 1.5T Zen Edition - Product Status
  • Table 37: Vantage Titan 1.5T Zen Edition - Product Description
  • Table 38: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Pediatric Cardiovascular MRI - Product Status
  • Table 40: Pediatric Cardiovascular MRI - Product Description
  • Table 41: Clear Cut Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: ClearSight System - Breast Biopsy - Product Status
  • Table 43: ClearSight System - Breast Biopsy - Product Description
  • Table 44: ClearSight System - Breast Cancer Lumpectomy - Product Status
  • Table 45: ClearSight System - Breast Cancer Lumpectomy - Product Description
  • Table 46: ClearSight System - Colorectal Cancer - Product Status
  • Table 47: ClearSight System - Colorectal Cancer - Product Description
  • Table 48: ClearSight System - Lung Cancer - Product Status
  • Table 49: ClearSight System - Lung Cancer - Product Description
  • Table 50: ClearSight System - Prostate Cancer - Product Status
  • Table 51: ClearSight System - Prostate Cancer - Product Description
  • Table 52: ClearSight System - Skin Cancer - Product Status
  • Table 53: ClearSight System - Skin Cancer - Product Description
  • Table 54: ClearSight System - Thyroid Cancer - Product Status
  • Table 55: ClearSight System - Thyroid Cancer - Product Description
  • Table 56: Clear Cut Medical Ltd. - Ongoing Clinical Trials Overview
  • Table 57: ClearSight System - Breast Cancer Lumpectomy - Clinical Study of the ClearSight System to Evaluate the Ability to Distinguish Malignant from Non-malignant Breast Tissue by Comparing MR Measurements of Freshly Excised Breast Tissue to Histopathology
  • Table 58: Diagnosoft Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Strain Encoding (SENC) Magnetic Resonance Imaging System - Product Status
  • Table 60: Strain Encoding (SENC) Magnetic Resonance Imaging System - Product Description
  • Table 61: Duke University Pipeline Products & Ongoing Clinical Trials Overview

1.2 List of Figures

  • Figure 1: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Stage of Development
  • Figure 2: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Segment
  • Figure 3: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Territory
  • Figure 4: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Regulatory Path
  • Figure 5: MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Estimated Approval Date
  • Figure 6: MRI (Magnetic Resonance Imaging) Systems - Ongoing Clinical Trials
目次
Product Code: GDME0768EPD

GlobalData's Medical Devices sector report, "MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline Assessment, 2019" provides an overview of MRI (Magnetic Resonance Imaging) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key MRI (Magnetic Resonance Imaging) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the MRI (Magnetic Resonance Imaging) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of MRI (Magnetic Resonance Imaging) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of MRI (Magnetic Resonance Imaging) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

  • 2.1 MRI (Magnetic Resonance Imaging) Systems Overview

3 Products under Development

  • 3.1 MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Stage of Development
  • 3.2 MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Segment
  • 3.3 MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Territory
  • 3.4 MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Regulatory Path
  • 3.5 MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Estimated Approval Date
  • 3.6 MRI (Magnetic Resonance Imaging) Systems - Ongoing Clinical Trials

4 MRI (Magnetic Resonance Imaging) Systems - Pipeline Products under Development by Companies

  • 4.1 MRI (Magnetic Resonance Imaging) Systems Companies - Pipeline Products by Stage of Development
  • 4.2 MRI (Magnetic Resonance Imaging) Systems - Pipeline Products by Stage of Development

5 MRI (Magnetic Resonance Imaging) Systems Companies and Product Overview

  • 5.1 Advanced MRI Technologies Company Overview
  • 5.2 ALA Scientific Instruments Inc Company Overview
  • 5.3 Aspect Imaging Inc Company Overview
  • 5.4 Boston Children's Hospital Company Overview
  • 5.5 Brigham and Women's Hospital Company Overview
  • 5.6 C4 Imaging, LLC Company Overview
  • 5.7 Canon Medical Systems Corp Company Overview
  • 5.8 Cincinnati Children's Hospital Medical Center Company Overview
  • 5.9 Clear Cut Medical Ltd. Company Overview
  • 5.10 Diagnosoft Inc Company Overview
  • 5.11 Duke University Company Overview
  • 5.12 GE Global Research Company Overview
  • 5.13 GE Healthcare LLC Company Overview
  • 5.14 Georgetown University Company Overview
  • 5.15 Harvard University Company Overview
  • 5.16 Hebrew University of Jerusalem Company Overview
  • 5.17 Hugo W. Moser Research Institute at Kennedy Krieger Inc Company Overview
  • 5.18 Icahn School of Medicine at Mount Sinai Company Overview
  • 5.19 Johns Hopkins University Company Overview
  • 5.20 KinetiCor Inc Company Overview
  • 5.21 Koninklijke Philips NV Company Overview
  • 5.22 Leiden University Company Overview
  • 5.23 Leiden University Medical Center Company Overview
  • 5.24 Marvel Medtech LLC Company Overview
  • 5.25 Massachusetts General Hospital Company Overview
  • 5.26 Max Delbruck Center for Molecular Medicine Company Overview
  • 5.27 Medical College of Wisconsin Company Overview
  • 5.28 Mitsubishi Electric Corp Company Overview
  • 5.29 MRI Robotics LLC Company Overview
  • 5.30 MR-Link LLC Company Overview
  • 5.31 Neurospin Company Overview
  • 5.32 Neusoft Medical Systems Co Ltd Company Overview
  • 5.33 New York University School of Medicine Company Overview
  • 5.34 Northwestern University Company Overview
  • 5.35 Oregon Health & Science University Company Overview
  • 5.36 Philips Healthcare Company Overview
  • 5.37 Picofemto LLC Company Overview
  • 5.38 Prism Clinical Imaging, Inc. Company Overview
  • 5.39 Promaxo Inc Company Overview
  • 5.40 Resonance Health Ltd Company Overview
  • 5.41 Robin Medical, Inc. Company Overview
  • 5.42 Shanghai United Imaging Healthcare Co Ltd Company Overview
  • 5.43 Siemens AG Company Overview
  • 5.44 Siemens Healthineers AG Company Overview
  • 5.45 Stanford University Company Overview
  • 5.46 Superconducting Systems Inc Company Overview
  • 5.47 Tel Aviv University Company Overview
  • 5.48 The University of Manchester Company Overview
  • 5.49 Time Medical, Inc. Company Overview
  • 5.50 Tornado Spectral Systems Company Overview
  • 5.51 University of Arizona Company Overview
  • 5.52 University of California Davis Company Overview
  • 5.53 University of California Los Angeles Company Overview
  • 5.54 University of Colorado Company Overview
  • 5.55 University of Colorado Boulder Company Overview
  • 5.56 University of Illinois Company Overview
  • 5.57 University of Louisville Company Overview
  • 5.58 University of Michigan Company Overview
  • 5.59 University of Nottingham Company Overview
  • 5.60 University of Queensland Company Overview
  • 5.61 University of Saskatchewan Company Overview
  • 5.62 University of Strasbourg Company Overview
  • 5.63 University of Texas Southwestern Medical Center Company Overview
  • 5.64 University of Virginia Company Overview
  • 5.65 University of Washington Company Overview
  • 5.66 Vanderbilt University Company Overview
  • 5.67 VisionQuest Biomedical LLC Company Overview
  • 5.68 Weinberg Medical Physics, LLC Company Overview
  • 5.69 Weizmann Institute of Science Company Overview
  • 5.70 Wright State University Company Overview

6 MRI (Magnetic Resonance Imaging) Systems- Recent Developments

  • 6.1 Apr 04, 2019: Varian opens office in South Africa to support regional growth
  • 6.2 Apr 04, 2019: BGU Researchers first to show how hackers can dupe radiologists and AI software by manipulating Lung Cancer Scans
  • 6.3 Apr 01, 2019: Amphion Innovations: Update on loan facility
  • 6.4 Mar 28, 2019: iCAD appoints Stacey Stevens as president
  • 6.5 Mar 28, 2019: Ultrasound and Open MRI Systems available to Intalere members through new agreement with Hitachi Healthcare Americas
  • 6.6 Mar 27, 2019: ContextVision names Fredrik Palm as new CEO
  • 6.7 Mar 26, 2019: Philips unveils new telehealth services for precision diagnoses
  • 6.8 Mar 25, 2019: EDP and European Commission promote deals between startups and global companies
  • 6.9 Mar 22, 2019: Fetal heart abnormalities detailed before birth by new 3D images
  • 6.10 Mar 21, 2019: Varian holds first meeting of FlashForward Consortium
  • 6.11 Mar 20, 2019: Salinas Valley Memorial Healthcare System establishes leadership in cardiac imaging on the West Coast with acquisition of Canon Medical Systems' Vantage Titan / Zen Edition

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top